Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Hippo Holdings (HIPO) has a Form 144 notice covering a planned sale of 3,645 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of 115,109.10 and are part of a larger base of 25,335,000 shares outstanding. The proposed sale date is 11/21/2025. The seller acquired 1,553 shares via restricted stock units on 05/15/2025 and 2,092 shares via performance stock units on 09/09/2025, both from the issuer. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Hippo’s current or prospective operations.
Hippo Holdings Inc. (HIPO) Chief Financial Officer Guy Zeltser reported equity transactions in company stock. On 11/15/2025, 4,182 shares of common stock were disposed of in a transaction coded "F," typically used for tax withholding related to equity awards, at a reported price of $31.1137 per share. On 11/18/2025, he sold 1,719 shares at a weighted average price of $32.1231 and an additional 100 shares at $32.74, in sales noted as made under a Rule 10b5-1 trading plan dated June 18, 2025. Following these transactions, Zeltser beneficially owns 68,860 shares of Hippo common stock, which includes 57,997 restricted stock units (RSUs).
Hippo Holdings Inc. (HIPO) reported an insider equity transaction by its GM & Chief Insurance, HHIP, Michael Stienstra. On 11/15/2025, a disposition coded "F" of 2,463 shares of common stock at $31.1137 per share was reported. After this transaction, Stienstra beneficially owned 75,181 shares, which includes 37,874 restricted stock units (RSUs). The filing reflects routine reporting of changes in an executive’s equity holdings.
Hippo Holdings Inc. (HIPO) reported an insider transaction by an officer identified as CEO Spinnaker. On 11/15/2025, the reporting person disposed of 2,123 shares of common stock in a transaction marked with code F at a price of $31.1137 per share. After this transaction, the reporting person beneficially owned 58,852 shares of Hippo common stock.
The reported holdings include 47,549 restricted stock units (RSUs), indicating that a significant portion of the position is in the form of equity awards that typically settle into shares over time.
Hippo Holdings Inc. (HIPO) reported that Chief Executive Officer and director Richard McCathron disposed of 11,326 shares of common stock on 11/15/2025 at a price of $31.1137 per share. After this transaction, he beneficially owns 457,704 shares of Hippo common stock, which the disclosure states includes 181,675 restricted stock units (RSUs). The filing is made on Form 4 as a single-reporting-person filing for McCathron in his roles as both director and officer.
HIPO filed a Form 144 covering a planned sale of 1,819 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,371.26. These shares come from restricted stock units acquired from the issuer on 11/15/2025, with payment also dated 11/15/2025. The filing notes that 25,335,179 shares of common stock were outstanding, providing a baseline for the company’s total equity. Over the prior three months, a Rule 10b5-1 trading plan for Guy Zeltser reported sales of 5,177 common shares for gross proceeds of $194,031.73.
Hippo Holdings (HIPO): Lennar Corporation and affiliated entities filed Amendment No. 4 to Schedule 13D reporting beneficial ownership of 2,169,580 shares of Hippo common stock, representing 8.6% of outstanding shares. The percentage is based on 25,335,179 shares outstanding as of October 29, 2025. One reporting person also holds an irrevocable proxy to vote 16,470 shares, while an agreement limits voting decisions to no more than 9.99% of Hippo’s voting interests.
The filing lists recent open‑market sales by LEN FW Investor, LLC: 119,780 shares on November 7, 2025 at a weighted‑average price of $33.87, and 62,058 shares on November 10, 2025 at $33.59, with additional sales on November 11 and 12, 2025 at weighted‑average prices of $33.22 and $34.06.
Hippo Holdings Inc. (HIPO) reported a sharp turnaround in Q3 2025, posting net income of $98.1 million versus a loss a year ago, as total revenue rose to $120.6 million from $95.5 million. Results were driven by a $95.0 million gain on the sale of its homebuilder distribution network, while underlying insurance metrics also improved: net earned premium reached $99.7 million (from $70.6 million) and losses and LAE fell to $47.5 million (from $51.6 million).
The balance sheet strengthened with total assets of $1.87 billion and Hippo stockholders’ equity of $421.5 million. Cash and cash equivalents increased to $247.7 million, supported by $75 million upfront proceeds from the sale and a new $50.0 million surplus note at a 9.5% fixed rate. The company repurchased 514,309 shares for $14.5 million and ended the quarter with 25,337,366 shares issued and outstanding. Hippo also simplified reporting to a single segment, reflecting how leadership now manages the business.
Hippo Holdings Inc. furnished an 8‑K announcing it issued materials for its quarter ended September 30, 2025. The company provided a press release, an investor presentation, and historical supplemental financial information.
The materials include non‑GAAP financial measures with reconciliations to GAAP. The information in Item 2.02 and Exhibits 99.1, 99.2, and 99.3 is furnished, not filed, and is not incorporated by reference unless specifically stated.
Hippo Holdings Inc. (HIPO) reported a director equity award on Form 4. On 10/01/2025, the director acquired 2,502 shares of Common Stock at $0.00, reported as a grant of restricted stock units (RSUs).
Each RSU converts into one share upon vesting, which occurs on the earlier of the first anniversary of the grant date or immediately prior to the next Annual Meeting following the grant, subject to continued service. After the reported transaction, 2,502 securities were beneficially owned, held directly.